Physician

Joshua Samuel Weir, D.O., M.B.A., M.S.

According to 2025 Medicare claims, Joshua Weir, D.O., M.B.A., M.S. (NPI: 1790102671) practices radiation oncology in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is WICHITA UROLOGY GROUP P.A. (NPI: 1639157498; TIN: 481253013) and primary practice location at 67226-8110.

Weir's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 535 traditional Medicare patients, billed 22,644 HCPCS/CPT codes, and received $3,294,401 in Medicare payments. The top billing code was 77338 (Design and construction of radiation treatment device for high precision radiation therapy). Part D data shows 491 prescription claims across 185 beneficiaries totaling $7,924 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 32 records totaling $1,082. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $37,181 to $3,294,401. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $7,543 and ending at $7,924. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.3M2019 Medicare payment: $37,181 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $150,383 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $339,533 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,829,081 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,977,680 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,294,401 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201981634$37,181
20202152,381$150,383
20212443,249$339,533
202229412,992$1,829,081
202342014,563$1,977,680
202453522,644$3,294,401

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.0K$7.9K2015 Drug cost: $7,543 (USD; Tot_Drug_Cst)2016 Drug cost: $464 (USD; Tot_Drug_Cst)2017 Drug cost: $1,562 (USD; Tot_Drug_Cst)2018 Drug cost: $2,398 (USD; Tot_Drug_Cst)2019 Drug cost: $1,224 (USD; Tot_Drug_Cst)2020 Drug cost: $384 (USD; Tot_Drug_Cst)2021 Drug cost: $769 (USD; Tot_Drug_Cst)2022 Drug cost: $3,416 (USD; Tot_Drug_Cst)2023 Drug cost: $7,602 (USD; Tot_Drug_Cst)2024 Drug cost: $7,924 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201531161$7,543
20161931$464
20175379$1,562
20184984$2,398
20192643$1,224
20201328$384
20212434$769
202282238$3,416
2023139423$7,602
2024185491$7,924

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77338Design and construction of radiation treatment device for high precision radiation therapy226442$160
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more281281$146
77263Complex radiation therapy planning277288$120
77336Continuing radiation therapy consultation per week264610$56
77300Calculation of radiation therapy dose3041,282$23

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tamsulosin HclTamsulosin Hcl34217,625$2,260
Lidocaine Hcl ViscousLidocaine Hcl2073$242
Oxybutynin ChlorideOxybutynin Chloride13510$219
MethylprednisoloneMethylprednisolone21136$174

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$1,082AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joshua Samuel Weir, D.O., M.B.A., M.S.?

Tedicare shows public-source Medicare data for Joshua Samuel Weir, D.O., M.B.A., M.S. (NPI 1790102671), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Samuel Weir, D.O., M.B.A., M.S. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joshua Samuel Weir, D.O., M.B.A., M.S.?

Joshua Samuel Weir, D.O., M.B.A., M.S. is linked to WICHITA UROLOGY GROUP P.A. (billing NPI 1639157498) in the available physician profile data.

Does Joshua Samuel Weir, D.O., M.B.A., M.S. have Open Payments data?

Joshua Samuel Weir, D.O., M.B.A., M.S. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.